D01
Authority & regime
No source-verified answer is published for this dimension yet.
0 source-linked facts
Ministério da Saúde Pública / UEMOA · Middle East & AfricaGuinea-Bissau medical device regulatory resources
Every Guinea-Bissau dataset, comparison, and AI workpaper we maintain — one entry point for the whole market.
1 free resources0/25 topics with records2 regulations tracked
Everything we track for Guinea-Bissau
Structured regulatory requirements
Explore all 0 source-linked facts →0 of 25 research dimensions currently covered · 0 official sources
Market entry
Unresolved
Open details →
D02
Legal basis & guidance
No source-verified answer is published for this dimension yet.
0 source-linked facts
D03
Device definition & scope
No source-verified answer is published for this dimension yet.
0 source-linked facts
D04
Classification rules
No source-verified answer is published for this dimension yet.
0 source-linked facts
D05
Registration pathways
No source-verified answer is published for this dimension yet.
0 source-linked facts
D06
Reliance & recognition
No source-verified answer is published for this dimension yet.
0 source-linked facts
D07
Economic-operator roles
No source-verified answer is published for this dimension yet.
0 source-linked facts
D08
Establishment, import & distribution
No source-verified answer is published for this dimension yet.
0 source-linked facts
D09
Dossier requirements
No source-verified answer is published for this dimension yet.
0 source-linked facts
D10
Official forms & portals
No source-verified answer is published for this dimension yet.
0 source-linked facts
Submission & evidence
D11
Label, IFU & language
No source-verified answer is published for this dimension yet.
0 source-linked facts
D12
QMS, audit & inspection
No source-verified answer is published for this dimension yet.
0 source-linked facts
D13
Standards, testing & ancillary approvals
No source-verified answer is published for this dimension yet.
0 source-linked facts
D14
Fees
No source-verified answer is published for this dimension yet.
0 source-linked facts
D15
Review clocks
No source-verified answer is published for this dimension yet.
0 source-linked facts
D16
Approval validity & renewal
No source-verified answer is published for this dimension yet.
0 source-linked facts
Lifecycle & post-market
D17
Change control
No source-verified answer is published for this dimension yet.
0 source-linked facts
D18
UDI, listing & traceability
No source-verified answer is published for this dimension yet.
0 source-linked facts
D19
Clinical investigation & performance
No source-verified answer is published for this dimension yet.
0 source-linked facts
D20
Special access & derogation
No source-verified answer is published for this dimension yet.
0 source-linked facts
D21
Manufacturer PMS
No source-verified answer is published for this dimension yet.
0 source-linked facts
D22
Vigilance & incident reporting
No source-verified answer is published for this dimension yet.
0 source-linked facts
D23
Recall, FSCA & market surveillance
No source-verified answer is published for this dimension yet.
0 source-linked facts
D24
Advertising, claims & promotion
No source-verified answer is published for this dimension yet.
0 source-linked facts
D25
Submission communications & appeal
No source-verified answer is published for this dimension yet.
0 source-linked facts
Key regulations
All 2 Guinea-Bissau regulations →Official Ministério da Saúde Pública / UEMOA rules and guidance · 2 of 2 documents linked to official sources
Despacho n.º 14/GMSP/2024, de 26 de setembro de 2024Aprovação da 5.ª edição da Lista de Medicamentos e Produtos Essenciais de Saúde, incluindo produtos prioritários de tecnologia assistiva
GeneralVerifiedDécision n° 03/2022/CM/UEMOA du 24 juin 2022, annexesLignes directrices relatives à l’harmonisation de la réglementation des dispositifs médicaux dans les États membres de l’UEMOA
GeneralVerifiedContinue with this market
Turn Guinea-Bissau research into practical work
The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.
Build a reusable product master
Structure company, product, model, approval, certificate, and evidence facts before starting Guinea-Bissau work.
Guinea-Bissau market-launch workpaper
Connect the Ministério da Saúde Pública / UEMOA route, evidence, labels, local role, timing, and dependencies to a wider launch plan.
Guinea-Bissau dossier reuse and delta
Compare an existing authorization and evidence set against Ministério da Saúde Pública / UEMOA administrative, testing, labeling, and dossier needs.
Guinea-Bissau change notification workpaper
Map a product or manufacturing change to Ministério da Saúde Pública / UEMOA evidence, notification, timing, and implementation questions.
Guinea-Bissau regulatory change impact
Assess a current Ministério da Saúde Pública / UEMOA update against one product and turn it into an owner-ready action workpaper.
Guinea-Bissau cybersecurity evidence review
Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Guinea-Bissau (Ministério da Saúde Pública / UEMOA).
Country hubs in other markets
Other Middle East & Africa markets
Algeria
Angola
Bahrain
Benin
Botswana
Burkina Faso
Burundi
Cabo Verde
Cameroon
Central African Republic
Chad
Comoros
Côte d'Ivoire
Democratic Republic of the Congo
Djibouti
Egypt
Equatorial Guinea
Eritrea
Eswatini
Ethiopia
Gabon
Gambia
Ghana
Guinea
Iran
Iraq
Israel
Jordan
Kenya
Kuwait
Lebanon
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Oman
Qatar
Republic of the Congo
Rwanda
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Tanzania
Togo
Tunisia
Uganda
United Arab Emirates
Zambia
ZimbabweAll 156 markets →
Entering the Guinea-Bissau market?
Local representation, Ministério da Saúde Pública / UEMOA submissions, and lifecycle maintenance — handled with an expert.